InPhocus: Current State and Challenges of Phage Research in Singapore

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Fulltext

    Final published version, 354 KB, PDF document

  • Navin Kumar Verma
  • Si Jia Tan
  • John Chen
  • Hanrong Chen
  • Muhammad Hafiz Ismail
  • Scott A Rice
  • Pablo Bifani
  • Sukumar Hariharan
  • Vivek Daniel Paul
  • Bharathi Sriram
  • Linh Chi Dam
  • Chia Ching Chan
  • Peiying Ho
  • Boon Chong Goh
  • Shimin Jasmine Chung
  • Kenneth Choon Meng Goh
  • Shu Hua Thong
  • Andrea Lay Hoon Kwa
  • Adam Ostrowski
  • Thet Tun Aung
  • Halimah Razali
  • Shermaine W. Y. Low
  • Mani Shankar Bhattacharyya
  • Hemant K. Gautam
  • Rajamani Lakshminarayanan
  • Martha R. J. Clokie
  • Wilfried Moreira
  • Maurice Adrianus Monique Van Steensel

Bacteriophages and phage-derived proteins are a promising class of antibacterial agents that experience a growing worldwide interest. To map ongoing phage research in Singapore and neighboring countries, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore (NTU) and Yong Loo Lin School of Medicine, National University of Singapore (NUS) recently co-organized a virtual symposium on Bacteriophage and Bacteriophage-Derived Technologies, which was attended by more than 80 participants. Topics were discussed relating to phage life cycles, diversity, the roles of phages in biofilms and the human gut microbiome, engineered phage lysins to combat polymicrobial infections in wounds, and the challenges and prospects of clinical phage therapy. This perspective summarizes major points discussed during the symposium and new perceptions that emerged after the panel discussion.

Original languageEnglish
JournalPHAGE: Therapy, Applications, and Research
Volume3
Issue number1
Pages (from-to)6-11
Number of pages6
ISSN2641-6530
DOIs
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© 2022, Mary Ann Liebert, Inc., publishers 2022.

    Research areas

  • antimicrobial resistance, ectolysin, filamentous phages, metagenomics, recombinant phage proteins

ID: 319235736